LONDON/COPENHAGEN (Reuters) -Danish drugmaker Novo Nordisk is facing a major challenge to its blockbuster weight-loss drug Wegovy. Booming sales of Wegovy powered the firm to become Europe's most ...
LONDON/COPENHAGEN, Dec 23 (Reuters) - Novo Nordisk ‌secured U.S. regulatory approval for its weight-loss pill, giving the Danish drugmaker a shot at reclaiming ground lost to rival Eli Lilly. Booming ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results